Today's picks
Top candidates from last night's scan. Scores refresh each evening; prices are live.
Some outbound links (e.g. TradingView) may be affiliate links. We may earn a commission at no extra cost to you.
Top candidates from last night's scan. Scores refresh each evening; prices are live.
Some outbound links (e.g. TradingView) may be affiliate links. We may earn a commission at no extra cost to you.
Evolent Health, Inc
$4.89
Very high debt.
Score band Watchlist, capped to Needs review: very high debt
Chart by TradingView
Passed
19
Failed
6
R:R
3.94:1
Confidence
high
Entry $4.89
Stop loss $4.67
Target $5.77
Quality 18/35 (4/8 passed)
Technical 30/40 (6/8 passed)
Trade setup 15/15 (4/4 passed)
Red flags 8/10 (1/6 triggered — informational, gates only)
Conviction total 70/100 — quality + technical + trade setup only. Unknown rules count as not passed.
Status: Known upside
Technical target: $6.63
Analyst target: $5.77
Effective target: $5.77
R:R 3.94:1
Entry: $4.89
Stop loss: $4.67
Effective target: $5.77
Rule-based analysis generated by Huntover. Not financial advice.
Some outbound links (e.g. TradingView) may be affiliate links. We may earn a commission at no extra cost to you.
Revenue is growing
Revenue growth is 46.9%.
Free cash flow is positive
Free cash flow is positive.
Market cap is not tiny / speculative
Market cap is $0.6B.
Valuation is not extreme
P/E unknown, P/S 0.3.
Price above 50-day moving average
Price $4.89 is above 50-day MA $4.76.
Price above 200-day moving average
Price is above 200-day MA $3.87.
50-day MA above 200-day MA
50-day MA is above 200-day MA (bullish alignment).
Price not near 52-week low
133.4% above 52-week low.
Stock is in an uptrend
Price up 30.7% over 20 days.
Breaking above recent resistance
Price near/above recent resistance $4.79.
Clear entry price exists
Current price $4.89 can be used as entry reference.
Stop loss no more than 10% below entry
Suggested stop at $4.67 (4.6% below entry).
Spread / liquidity risk acceptable
Average daily volume is 3.09M.
No earnings within 7 days
Next earnings in 72 days.
Price near 52-week low
Not near 52-week low.
Very low trading volume
Volume is not unusually low.
Recent large price drop
No recent large drop detected.
Extreme valuation
Valuation is not extreme.
Missing too much data
2 data field(s) missing.
Company is profitable
Profit margin is -24.1% (not profitable).
Debt is manageable
Debt-to-equity is 253.2% (elevated).
Return on equity or capital is positive
Both ROE and ROA are not positive.
Price near 52-week high
51.5% below 52-week high.
Recent volume above average
Volume is only 0.93x the average.
Very high debt
Debt-to-equity 253.2% is very high.
EPS / earnings are growing
Earnings growth data unavailable.
Yahoo Finance did not return these inputs, so related rules may be marked unknown.
